Metethoheptazine
From Wikipedia, the free encyclopedia
|
Metethoheptazine
|
|
| Systematic (IUPAC) name | |
| ethyl 1,3-dimethyl-4-phenylazepane-4-carboxylate | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C17H25NO2 |
| Mol. mass | 275.39 g/mol |
| Synonyms | Metethoheptazine, WY-535 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Metethoheptazine (WY-535) is an opioid analgesic from the phenazepine family. It was invented in the 1960s.[1]
Metethoheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.
[edit] References
- ^ Walkenstein SS, Corradino RA, Wiser R, Gudmundsen CH. Metabolism of the Non-Narcotic Analgesic, WY-535. Biochemical Pharmacology. 1965 Feb;14:121-8.

